Immunotherapy-chemotherapy treatment coupled with in-depth genomic analyses leads to…
Combining the immunotherapy agent durvalumab with the chemotherapy agents pemetrexed and cisplatin or carboplatin may provide a new treatment option for patients who have inoperable pleural…